Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneicstem cell transplant
I. Munoz et al., Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneicstem cell transplant, J MED VIROL, 65(1), 2001, pp. 77-84
The kinetics of the gB-specific and neutralizing antibody responses to huma
n cytomegalovirus (HCMV) were analyzed in 26 allogeneic stem-cell transplan
t recipients who either did (n = 20) or did not (n = 6) develop asymptomati
c HCMV active infection during the study period. Antibody response profiles
varied widely among individuals in both groups, irrespective of whether HC
MV active infection did or did not occur. Development of HCMV active infect
ion was not preceded by a decline in functional serum antibody levels. Neit
her the absence nor the presence of HCMV active infection correlated with e
ither high or low serum levels of gB-specific and neutralizing antibodies,
respectively. In most patients, episodes of HCMV replication were not follo
wed by a marked increment in functional serum antibody titers. Therefore, r
esolution of an ongoing HCMV active infection was not associated with a vig
orous antibody response to viral replication. In addition, this study suppo
rts previous data indicating that passive transfer of human immunoglobulins
may result in an increment in gB-specific and neutralizing serum antibody
levels, the magnitude of which varies among recipients; however, both patie
nts with and without measurable increments in serum antibody levels develop
ed HCMV active infections with comparable frequency. (C) 2001 Wiley-Liss, I
nc.